In rat models of ARDS, VNS modulates the inflammatory response by decreasing pro-inflammatory cytokines (e.g., TNF-α and IL-1β) and enhancing anti-inflammatory cytokines (e.g., IL-10), thereby mitigating lung injury [7]. This evidence concerns the gene IL1B and acute respiratory distress syndrome.